Peter Stiegler
- Oncology top 10%
- Cancer-related Molecular Pathways 11
-
- Ubiquitin and proteasome pathways 6
- Histone Deacetylase Inhibitors Research 3
- Epigenetics and DNA Methylation 3
- Genomics and Chromatin Dynamics 3
- RNA modifications and cancer 2
-
- Cancer, Hypoxia, and Metabolism 2
- Ophthalmology top 10%
-
- Virus-based gene therapy research 3
- Co-authors
- Antonio GiordanoLuigi BagellaAntonio De LucaPrem PuriMargaret M. KastenPier Paolo ClaudioVittorio SartorelliR. Louis Schiltz
- Journals
- Journal of Cellular Biochemistry (4 papers)Oncogene (4 papers)Journal of Cellular Physiology (3 papers)
- Partner nations
- United StatesItalyAustria
In The Last Decade
Peter Stiegler
20 papers receiving 723 citations
Peers
Comparison fields: 5 of 71
- Oncology 270
- Molecular Biology 586
- Cancer Research 71
- Virology 20
- Ophthalmology 32
Countries citing papers authored by Peter Stiegler
This map shows the geographic impact of Peter Stiegler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Stiegler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Stiegler more than expected).
Fields of papers citing papers by Peter Stiegler
This network shows the impact of papers produced by Peter Stiegler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Stiegler. The network helps show where Peter Stiegler may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Stiegler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 30 | |
| 2 | 2003 | 14 | |
| 3 | 2002 | 93 | |
| 4 | 2001 | 175 | |
| 5 | 2001 | 31 | |
| 6 | 2001 | 15 | |
| 7 | RB2/p130 gene-enhanced expression down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in vivo. | 2001 | 35 |
| 8 | 2000 | 2 | |
| 9 | 2000 | 1 | |
| 10 | 2000 | 12 | |
| 11 | Inducible pRb2/p130 expression and growth-suppressive mechanisms: evidence of a pRb2/p130, p27Kip1, and cyclin E negative feedback regulatory loop. | 2000 | 48 |
| 12 | 1999 | 1 | |
| 13 | Role of pRB2/p130 in cellular growth regulation. | 1999 | 4 |
| 14 | 1998 | 7 | |
| 15 | 1998 | 5 | |
| 16 | 1998 | 101 | |
| 17 | The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter. | 1998 | 82 |
| 18 | 1998 | 62 | |
| 19 | 1997 | 6 | |
| 20 | 1997 | 6 |
About Peter Stiegler
Peter Stiegler is a scholar working on Oncology, Ophthalmology and Molecular Biology, having authored 20 papers that have together received 730 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (11 papers), Ubiquitin and proteasome pathways (6 papers), Virus-based gene therapy research (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Epigenetics and DNA Methylation (3 papers), Genomics and Chromatin Dynamics (3 papers), RNA modifications and cancer (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Oncology (270 citations), Molecular Biology (586 citations) and Cancer Research (71 citations). Peter Stiegler has collaborated with scholars based in United States, Italy and Austria. Frequent co-authors include Antonio Giordano, Luigi Bagella, Antonio De Luca, Prem Puri, Margaret M. Kasten, Pier Paolo Claudio, Vittorio Sartorelli, R. Louis Schiltz, George E.O. Muscat and Jean Y. J. Wang. Their work appears in journals such as Journal of Cellular Biochemistry, Oncogene, Journal of Cellular Physiology, Critical Reviews in Eukaryotic Gene Expression and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.